Augere Medical strengthens its management team
14 févr. 2025 02h00 HE
|
Augere Medical AS
OSLO, Norway, Feb. 14, 2025 (GLOBE NEWSWIRE) -- After the MDR CE-mark for its Class IIb PolypAID™ system and the recent “first close” NOK 23M (USD 2.1M) financing round, the company strengthens its...
Augere Medical secures NOK 23M in the “first close” funding round
19 nov. 2024 04h00 HE
|
Augere Medical AS
OSLO, Norway, Nov. 19, 2024 (GLOBE NEWSWIRE) -- On back of the MDR CE-mark for its Class IIb PolypAID™ system which the company secured in August, Augere has secured NOK 23M (USD 2.1M) for its...